“G-protein Coupled Receptors (GPCRs): A Potential Target of Apigenin as a Novel hACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients”, EJPHARMA, vol. 5, no. 1, pp. 6–15, May 2025, doi: 10.24018/ejpharma.2025.5.1.85.